Summary
Sales outsourcing is simply this: outsourcing a portion or entire sales activities to a trusted 3rd party sales team. Using a sales outsourcing partner allows companies to attract and maintain a sales force without having to make them full or part-time employees.
According to APO Research, The global Botanical Drug market is projected to grow from US$ million in 2024 to US$ million by 2030, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.
The US & Canada market for Botanical Drug is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
Asia-Pacific market for Botanical Drug is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
The China market for Botanical Drug is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
Europe market for Botanical Drug is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
The major global companies of Botanical Drug include Buchang Pharmaceuticals, China TCM, Tsumura, Schwabe, Tong Ren Tang, Jumpcan Pharmaceutical, Guangzhou Baiyunshan Pharmaceutical, Yunnan Baiyao and Tasly Holding Group, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
Report Includes
This report presents an overview of global market for Botanical Drug, market size. Analyses of the global market trends, with historic market revenue data for 2019 - 2023, estimates for 2024, and projections of CAGR through 2030.
This report researches the key producers of Botanical Drug, also provides the revenue of main regions and countries. Of the upcoming market potential for Botanical Drug, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Botanical Drug revenue, market share and industry ranking of main manufacturers, data from 2019 to 2024. Identification of the major stakeholders in the global Botanical Drug market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2019 to 2030. Evaluation and forecast the market size for Botanical Drug revenue, projected growth trends, production technology, application and end-user industry.
Botanical Drug segment by Company
Buchang Pharmaceuticals
China TCM
Tsumura
Schwabe
Tong Ren Tang
Jumpcan Pharmaceutical
Guangzhou Baiyunshan Pharmaceutical
Yunnan Baiyao
Tasly Holding Group
Bionorica Se
Huarun 999
Taiji
Weleda
Kwangdong
GW Pharmaceuticals
Botanical Drug segment by Type
Prescription Drug
OTC
Botanical Drug segment by Application
Cardiovascular
Tumor
Respiratory System
Others
Botanical Drug segment by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Study Objectives
1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.
2. To present the key players, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Botanical Drug market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Botanical Drug and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in market size), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Botanical Drug.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Revenue of Botanical Drug in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 4: Detailed analysis of Botanical Drug company competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 5: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 6: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 7: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Botanical Drug revenue, gross margin, and recent development, etc.
Chapter 8: North America (US & Canada) by type, by application and by country, revenue for each segment.
Chapter 9: Europe by type, by application and by country, revenue for each segment.
Chapter 10: China type, by application, revenue for each segment.
Chapter 11: Asia (excluding China) type, by application and by region, revenue for each segment.
Chapter 12: Middle East, Africa, and Latin America type, by application and by country, revenue for each segment.
Chapter 13: The main concluding insights of the report.
1 Market Overview
1.1 Product Definition
1.2 Botanical Drug Market by Type
1.2.1 Global Botanical Drug Market Size by Type, 2019 VS 2023 VS 2030
1.2.2 Prescription Drug
1.2.3 OTC
1.3 Botanical Drug Market by Application
1.3.1 Global Botanical Drug Market Size by Application, 2019 VS 2023 VS 2030
1.3.2 Cardiovascular
1.3.3 Tumor
1.3.4 Respiratory System
1.3.5 Others
1.4 Assumptions and Limitations
1.5 Study Goals and Objectives
2 Botanical Drug Market Dynamics
2.1 Botanical Drug Industry Trends
2.2 Botanical Drug Industry Drivers
2.3 Botanical Drug Industry Opportunities and Challenges
2.4 Botanical Drug Industry Restraints
3 Global Growth Perspective
3.1 Global Botanical Drug Market Perspective (2019-2030)
3.2 Global Botanical Drug Growth Trends by Region
3.2.1 Global Botanical Drug Market Size by Region: 2019 VS 2023 VS 2030
3.2.2 Global Botanical Drug Market Size by Region (2019-2024)
3.2.3 Global Botanical Drug Market Size by Region (2025-2030)
4 Competitive Landscape by Players
4.1 Global Botanical Drug Revenue by Players
4.1.1 Global Botanical Drug Revenue by Players (2019-2024)
4.1.2 Global Botanical Drug Revenue Market Share by Players (2019-2024)
4.1.3 Global Botanical Drug Players Revenue Share Top 10 and Top 5 in 2023
4.2 Global Botanical Drug Key Players Ranking, 2022 VS 2023 VS 2024
4.3 Global Botanical Drug Key Players Headquarters & Area Served
4.4 Global Botanical Drug Players, Product Type & Application
4.5 Global Botanical Drug Players Commercialization Time
4.6 Market Competitive Analysis
4.6.1 Global Botanical Drug Market CR5 and HHI
4.6.2 Global Top 5 and 10 Botanical Drug Players Market Share by Revenue in 2023
4.6.3 2023 Botanical Drug Tier 1, Tier 2, and Tier 3
5 Botanical Drug Market Size by Type
5.1 Global Botanical Drug Revenue by Type (2019 VS 2023 VS 2030)
5.2 Global Botanical Drug Revenue by Type (2019-2030)
5.3 Global Botanical Drug Revenue Market Share by Type (2019-2030)
6 Botanical Drug Market Size by Application
6.1 Global Botanical Drug Revenue by Application (2019 VS 2023 VS 2030)
6.2 Global Botanical Drug Revenue by Application (2019-2030)
6.3 Global Botanical Drug Revenue Market Share by Application (2019-2030)
7 Company Profiles
7.1 Buchang Pharmaceuticals
7.1.1 Buchang Pharmaceuticals Comapny Information
7.1.2 Buchang Pharmaceuticals Business Overview
7.1.3 Buchang Pharmaceuticals Botanical Drug Revenue and Gross Margin (2019-2024)
7.1.4 Buchang Pharmaceuticals Botanical Drug Product Portfolio
7.1.5 Buchang Pharmaceuticals Recent Developments
7.2 China TCM
7.2.1 China TCM Comapny Information
7.2.2 China TCM Business Overview
7.2.3 China TCM Botanical Drug Revenue and Gross Margin (2019-2024)
7.2.4 China TCM Botanical Drug Product Portfolio
7.2.5 China TCM Recent Developments
7.3 Tsumura
7.3.1 Tsumura Comapny Information
7.3.2 Tsumura Business Overview
7.3.3 Tsumura Botanical Drug Revenue and Gross Margin (2019-2024)
7.3.4 Tsumura Botanical Drug Product Portfolio
7.3.5 Tsumura Recent Developments
7.4 Schwabe
7.4.1 Schwabe Comapny Information
7.4.2 Schwabe Business Overview
7.4.3 Schwabe Botanical Drug Revenue and Gross Margin (2019-2024)
7.4.4 Schwabe Botanical Drug Product Portfolio
7.4.5 Schwabe Recent Developments
7.5 Tong Ren Tang
7.5.1 Tong Ren Tang Comapny Information
7.5.2 Tong Ren Tang Business Overview
7.5.3 Tong Ren Tang Botanical Drug Revenue and Gross Margin (2019-2024)
7.5.4 Tong Ren Tang Botanical Drug Product Portfolio
7.5.5 Tong Ren Tang Recent Developments
7.6 Jumpcan Pharmaceutical
7.6.1 Jumpcan Pharmaceutical Comapny Information
7.6.2 Jumpcan Pharmaceutical Business Overview
7.6.3 Jumpcan Pharmaceutical Botanical Drug Revenue and Gross Margin (2019-2024)
7.6.4 Jumpcan Pharmaceutical Botanical Drug Product Portfolio
7.6.5 Jumpcan Pharmaceutical Recent Developments
7.7 Guangzhou Baiyunshan Pharmaceutical
7.7.1 Guangzhou Baiyunshan Pharmaceutical Comapny Information
7.7.2 Guangzhou Baiyunshan Pharmaceutical Business Overview
7.7.3 Guangzhou Baiyunshan Pharmaceutical Botanical Drug Revenue and Gross Margin (2019-2024)
7.7.4 Guangzhou Baiyunshan Pharmaceutical Botanical Drug Product Portfolio
7.7.5 Guangzhou Baiyunshan Pharmaceutical Recent Developments
7.8 Yunnan Baiyao
7.8.1 Yunnan Baiyao Comapny Information
7.8.2 Yunnan Baiyao Business Overview
7.8.3 Yunnan Baiyao Botanical Drug Revenue and Gross Margin (2019-2024)
7.8.4 Yunnan Baiyao Botanical Drug Product Portfolio
7.8.5 Yunnan Baiyao Recent Developments
7.9 Tasly Holding Group
7.9.1 Tasly Holding Group Comapny Information
7.9.2 Tasly Holding Group Business Overview
7.9.3 Tasly Holding Group Botanical Drug Revenue and Gross Margin (2019-2024)
7.9.4 Tasly Holding Group Botanical Drug Product Portfolio
7.9.5 Tasly Holding Group Recent Developments
7.10 Bionorica Se
7.10.1 Bionorica Se Comapny Information
7.10.2 Bionorica Se Business Overview
7.10.3 Bionorica Se Botanical Drug Revenue and Gross Margin (2019-2024)
7.10.4 Bionorica Se Botanical Drug Product Portfolio
7.10.5 Bionorica Se Recent Developments
7.11 Huarun 999
7.11.1 Huarun 999 Comapny Information
7.11.2 Huarun 999 Business Overview
7.11.3 Huarun 999 Botanical Drug Revenue and Gross Margin (2019-2024)
7.11.4 Huarun 999 Botanical Drug Product Portfolio
7.11.5 Huarun 999 Recent Developments
7.12 Taiji
7.12.1 Taiji Comapny Information
7.12.2 Taiji Business Overview
7.12.3 Taiji Botanical Drug Revenue and Gross Margin (2019-2024)
7.12.4 Taiji Botanical Drug Product Portfolio
7.12.5 Taiji Recent Developments
7.13 Weleda
7.13.1 Weleda Comapny Information
7.13.2 Weleda Business Overview
7.13.3 Weleda Botanical Drug Revenue and Gross Margin (2019-2024)
7.13.4 Weleda Botanical Drug Product Portfolio
7.13.5 Weleda Recent Developments
7.14 Kwangdong
7.14.1 Kwangdong Comapny Information
7.14.2 Kwangdong Business Overview
7.14.3 Kwangdong Botanical Drug Revenue and Gross Margin (2019-2024)
7.14.4 Kwangdong Botanical Drug Product Portfolio
7.14.5 Kwangdong Recent Developments
7.15 GW Pharmaceuticals
7.15.1 GW Pharmaceuticals Comapny Information
7.15.2 GW Pharmaceuticals Business Overview
7.15.3 GW Pharmaceuticals Botanical Drug Revenue and Gross Margin (2019-2024)
7.15.4 GW Pharmaceuticals Botanical Drug Product Portfolio
7.15.5 GW Pharmaceuticals Recent Developments
8 North America
8.1 North America Botanical Drug Revenue (2019-2030)
8.2 North America Botanical Drug Revenue by Type (2019-2030)
8.2.1 North America Botanical Drug Revenue by Type (2019-2024)
8.2.2 North America Botanical Drug Revenue by Type (2025-2030)
8.3 North America Botanical Drug Revenue Share by Type (2019-2030)
8.4 North America Botanical Drug Revenue by Application (2019-2030)
8.4.1 North America Botanical Drug Revenue by Application (2019-2024)
8.4.2 North America Botanical Drug Revenue by Application (2025-2030)
8.5 North America Botanical Drug Revenue Share by Application (2019-2030)
8.6 North America Botanical Drug Revenue by Country
8.6.1 North America Botanical Drug Revenue by Country (2019 VS 2023 VS 2030)
8.6.2 North America Botanical Drug Revenue by Country (2019-2024)
8.6.3 North America Botanical Drug Revenue by Country (2025-2030)
8.6.4 United States
8.6.5 Canada
9 Europe
9.1 Europe Botanical Drug Revenue (2019-2030)
9.2 Europe Botanical Drug Revenue by Type (2019-2030)
9.2.1 Europe Botanical Drug Revenue by Type (2019-2024)
9.2.2 Europe Botanical Drug Revenue by Type (2025-2030)
9.3 Europe Botanical Drug Revenue Share by Type (2019-2030)
9.4 Europe Botanical Drug Revenue by Application (2019-2030)
9.4.1 Europe Botanical Drug Revenue by Application (2019-2024)
9.4.2 Europe Botanical Drug Revenue by Application (2025-2030)
9.5 Europe Botanical Drug Revenue Share by Application (2019-2030)
9.6 Europe Botanical Drug Revenue by Country
9.6.1 Europe Botanical Drug Revenue by Country (2019 VS 2023 VS 2030)
9.6.2 Europe Botanical Drug Revenue by Country (2019-2024)
9.6.3 Europe Botanical Drug Revenue by Country (2025-2030)
9.6.4 Germany
9.6.5 France
9.6.6 U.K.
9.6.7 Italy
9.6.8 Russia
10 China
10.1 China Botanical Drug Revenue (2019-2030)
10.2 China Botanical Drug Revenue by Type (2019-2030)
10.2.1 China Botanical Drug Revenue by Type (2019-2024)
10.2.2 China Botanical Drug Revenue by Type (2025-2030)
10.3 China Botanical Drug Revenue Share by Type (2019-2030)
10.4 China Botanical Drug Revenue by Application (2019-2030)
10.4.1 China Botanical Drug Revenue by Application (2019-2024)
10.4.2 China Botanical Drug Revenue by Application (2025-2030)
10.5 China Botanical Drug Revenue Share by Application (2019-2030)
11 Asia (Excluding China)
11.1 Asia Botanical Drug Revenue (2019-2030)
11.2 Asia Botanical Drug Revenue by Type (2019-2030)
11.2.1 Asia Botanical Drug Revenue by Type (2019-2024)
11.2.2 Asia Botanical Drug Revenue by Type (2025-2030)
11.3 Asia Botanical Drug Revenue Share by Type (2019-2030)
11.4 Asia Botanical Drug Revenue by Application (2019-2030)
11.4.1 Asia Botanical Drug Revenue by Application (2019-2024)
11.4.2 Asia Botanical Drug Revenue by Application (2025-2030)
11.5 Asia Botanical Drug Revenue Share by Application (2019-2030)
11.6 Asia Botanical Drug Revenue by Country
11.6.1 Asia Botanical Drug Revenue by Country (2019 VS 2023 VS 2030)
11.6.2 Asia Botanical Drug Revenue by Country (2019-2024)
11.6.3 Asia Botanical Drug Revenue by Country (2025-2030)
11.6.4 Japan
11.6.5 South Korea
11.6.6 India
11.6.7 Australia
11.6.8 China Taiwan
11.6.9 Southeast Asia
12 Middle East, Africa, Latin America
12.1 MEALA Botanical Drug Revenue (2019-2030)
12.2 MEALA Botanical Drug Revenue by Type (2019-2030)
12.2.1 MEALA Botanical Drug Revenue by Type (2019-2024)
12.2.2 MEALA Botanical Drug Revenue by Type (2025-2030)
12.3 MEALA Botanical Drug Revenue Share by Type (2019-2030)
12.4 MEALA Botanical Drug Revenue by Application (2019-2030)
12.4.1 MEALA Botanical Drug Revenue by Application (2019-2024)
12.4.2 MEALA Botanical Drug Revenue by Application (2025-2030)
12.5 MEALA Botanical Drug Revenue Share by Application (2019-2030)
12.6 MEALA Botanical Drug Revenue by Country
12.6.1 MEALA Botanical Drug Revenue by Country (2019 VS 2023 VS 2030)
12.6.2 MEALA Botanical Drug Revenue by Country (2019-2024)
12.6.3 MEALA Botanical Drug Revenue by Country (2025-2030)
12.6.4 Mexico
12.6.5 Brazil
12.6.6 Israel
12.6.7 Argentina
12.6.8 Colombia
12.6.9 Turkey
12.6.10 Saudi Arabia
12.6.11 UAE
13 Concluding Insights
14 Appendix
14.1 Reasons for Doing This Study
14.2 Research Methodology
14.3 Research Process
14.4 Authors List of This Report
14.5 Data Source
14.5.1 Secondary Sources
14.5.2 Primary Sources
14.6 Disclaimer
List of Tables
Table 1. Global Botanical Drug Market Size Growth Rate by Type (US$ Million), 2019 VS 2023 VS 2030
Table 1. Prescription Drug Major Manufacturers
Table 2. OTC Major Manufacturers
Table 3. Global Botanical Drug Market Size Growth Rate by Application (US$ Million), 2019 VS 2023 VS 2030
Table 4. Cardiovascular Major Manufacturers
Table 5. Tumor Major Manufacturers
Table 6. Respiratory System Major Manufacturers
Table 7. Others Major Manufacturers
Table 8. Botanical Drug Industry Trends
Table 9. Botanical Drug Industry Drivers
Table 10. Botanical Drug Industry Opportunities and Challenges
Table 11. Botanical Drug Industry Restraints
Table 12. Global Botanical Drug Market Size Growth Rate (CAGR) by Region (US$ Million): 2019 VS 2023 VS 2030
Table 13. Global Botanical Drug Market Size by Region (2019-2024) & (US$ Million)
Table 14. Global Botanical Drug Market Share by Region (2019-2024)
Table 15. Global Botanical Drug Market Size by Region (2025-2030) & (US$ Million)
Table 16. Global Botanical Drug Market Share by Region (2025-2030)
Table 17. Global Botanical Drug Revenue by Players (US$ Million) & (2019-2024)
Table 18. Global Botanical Drug Revenue Market Share by Players (2019-2024)
Table 19. Global Botanical Drug Key Players Ranking, 2022 VS 2023 VS 2024
Table 20. Global Botanical Drug Key Players Headquarters & Area Served
Table 21. Global Botanical Drug Players, Product Type & Application
Table 22. Global Botanical Drug Players Commercialization Time
Table 23. Global Players Market Concentration Ratio (CR5 and HHI)
Table 24. Global Botanical Drug by Players Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2023)
Table 25. Global Botanical Drug Revenue by Type 2019 VS 2023 VS 2030 (US$ Million)
Table 26. Global Botanical Drug Revenue by Type (2019-2024) & (US$ Million)
Table 27. Global Botanical Drug Revenue by Type (2025-2030) & (US$ Million)
Table 28. Global Botanical Drug Revenue Market Share by Type (2019-2024) & (US$ Million)
Table 29. Global Botanical Drug Revenue Market Share by Type (2025-2030) & (US$ Million)
Table 30. Global Botanical Drug Revenue by Application 2019 VS 2023 VS 2030 (US$ Million)
Table 31. Global Botanical Drug Revenue by Application (2019-2024) & (US$ Million)
Table 32. Global Botanical Drug Revenue by Application (2025-2030) & (US$ Million)
Table 33. Global Botanical Drug Revenue Market Share by Application (2019-2024) & (US$ Million)
Table 34. Global Botanical Drug Revenue Market Share by Application (2025-2030) & (US$ Million)
Table 35. Buchang Pharmaceuticals Company Information
Table 36. Buchang Pharmaceuticals Business Overview
Table 37. Buchang Pharmaceuticals Botanical Drug Revenue and Gross Margin (US$ Million) & (2019-2024)
Table 38. Buchang Pharmaceuticals Botanical Drug Product Portfolio
Table 39. Buchang Pharmaceuticals Recent Development
Table 40. China TCM Company Information
Table 41. China TCM Business Overview
Table 42. China TCM Botanical Drug Revenue and Gross Margin (US$ Million) & (2019-2024)
Table 43. China TCM Botanical Drug Product Portfolio
Table 44. China TCM Recent Development
Table 45. Tsumura Company Information
Table 46. Tsumura Business Overview
Table 47. Tsumura Botanical Drug Revenue and Gross Margin (US$ Million) & (2019-2024)
Table 48. Tsumura Botanical Drug Product Portfolio
Table 49. Tsumura Recent Development
Table 50. Schwabe Company Information
Table 51. Schwabe Business Overview
Table 52. Schwabe Botanical Drug Revenue and Gross Margin (US$ Million) & (2019-2024)
Table 53. Schwabe Botanical Drug Product Portfolio
Table 54. Schwabe Recent Development
Table 55. Tong Ren Tang Company Information
Table 56. Tong Ren Tang Business Overview
Table 57. Tong Ren Tang Botanical Drug Revenue and Gross Margin (US$ Million) & (2019-2024)
Table 58. Tong Ren Tang Botanical Drug Product Portfolio
Table 59. Tong Ren Tang Recent Development
Table 60. Jumpcan Pharmaceutical Company Information
Table 61. Jumpcan Pharmaceutical Business Overview
Table 62. Jumpcan Pharmaceutical Botanical Drug Revenue and Gross Margin (US$ Million) & (2019-2024)
Table 63. Jumpcan Pharmaceutical Botanical Drug Product Portfolio
Table 64. Jumpcan Pharmaceutical Recent Development
Table 65. Guangzhou Baiyunshan Pharmaceutical Company Information
Table 66. Guangzhou Baiyunshan Pharmaceutical Business Overview
Table 67. Guangzhou Baiyunshan Pharmaceutical Botanical Drug Revenue and Gross Margin (US$ Million) & (2019-2024)
Table 68. Guangzhou Baiyunshan Pharmaceutical Botanical Drug Product Portfolio
Table 69. Guangzhou Baiyunshan Pharmaceutical Recent Development
Table 70. Yunnan Baiyao Company Information
Table 71. Yunnan Baiyao Business Overview
Table 72. Yunnan Baiyao Botanical Drug Revenue and Gross Margin (US$ Million) & (2019-2024)
Table 73. Yunnan Baiyao Botanical Drug Product Portfolio
Table 74. Yunnan Baiyao Recent Development
Table 75. Tasly Holding Group Company Information
Table 76. Tasly Holding Group Business Overview
Table 77. Tasly Holding Group Botanical Drug Revenue and Gross Margin (US$ Million) & (2019-2024)
Table 78. Tasly Holding Group Botanical Drug Product Portfolio
Table 79. Tasly Holding Group Recent Development
Table 80. Bionorica Se Company Information
Table 81. Bionorica Se Business Overview
Table 82. Bionorica Se Botanical Drug Revenue and Gross Margin (US$ Million) & (2019-2024)
Table 83. Bionorica Se Botanical Drug Product Portfolio
Table 84. Bionorica Se Recent Development
Table 85. Huarun 999 Company Information
Table 86. Huarun 999 Business Overview
Table 87. Huarun 999 Botanical Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 88. Huarun 999 Botanical Drug Product Portfolio
Table 89. Huarun 999 Recent Development
Table 90. Taiji Company Information
Table 91. Taiji Business Overview
Table 92. Taiji Botanical Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 93. Taiji Botanical Drug Product Portfolio
Table 94. Taiji Recent Development
Table 95. Weleda Company Information
Table 96. Weleda Business Overview
Table 97. Weleda Botanical Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 98. Weleda Botanical Drug Product Portfolio
Table 99. Weleda Recent Development
Table 100. Kwangdong Company Information
Table 101. Kwangdong Business Overview
Table 102. Kwangdong Botanical Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 103. Kwangdong Botanical Drug Product Portfolio
Table 104. Kwangdong Recent Development
Table 105. GW Pharmaceuticals Company Information
Table 106. GW Pharmaceuticals Business Overview
Table 107. GW Pharmaceuticals Botanical Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 108. GW Pharmaceuticals Botanical Drug Product Portfolio
Table 109. GW Pharmaceuticals Recent Development
Table 110. North America Botanical Drug Revenue by Type (2019-2024) & (US$ Million)
Table 111. North America Botanical Drug Revenue by Application (2019-2024) & (US$ Million)
Table 112. North America Botanical Drug Revenue by Country (2019 VS 2023 VS 2030) & (US$ Million)
Table 113. North America Botanical Drug Revenue by Country (2019-2024) & (US$ Million)
Table 114. North America Botanical Drug Revenue by Country (2025-2030) & (US$ Million)
Table 115. Europe Botanical Drug Revenue by Type (2019-2024) & (US$ Million)
Table 116. Europe Botanical Drug Revenue by Application (2019-2024) & (US$ Million)
Table 117. Europe Botanical Drug Revenue by Country (2019 VS 2023 VS 2030) & (US$ Million)
Table 118. Europe Botanical Drug Revenue by Country (2019-2024) & (US$ Million)
Table 119. Europe Botanical Drug Revenue by Country (2025-2030) & (US$ Million)
Table 120. China Botanical Drug Revenue by Type (2019-2024) & (US$ Million)
Table 121. China Botanical Drug Revenue by Application (2019-2024) & (US$ Million)
Table 122. Asia Botanical Drug Revenue by Type (2019-2024) & (US$ Million)
Table 123. Asia Botanical Drug Revenue by Application (2019-2024) & (US$ Million)
Table 124. Asia Botanical Drug Revenue by Country (2019 VS 2023 VS 2030) & (US$ Million)
Table 125. Asia Botanical Drug Revenue by Country (2019-2024) & (US$ Million)
Table 126. Asia Botanical Drug Revenue by Country (2025-2030) & (US$ Million)
Table 127. MEALA Botanical Drug Revenue by Type (2019-2024) & (US$ Million)
Table 128. MEALA Botanical Drug Revenue by Application (2019-2024) & (US$ Million)
Table 129. MEALA Botanical Drug Revenue by Country (2019 VS 2023 VS 2030) & (US$ Million)
Table 130. MEALA Botanical Drug Revenue by Country (2019-2024) & (US$ Million)
Table 131. MEALA Botanical Drug Revenue by Country (2025-2030) & (US$ Million)
Table 132. Research Programs/Design for This Report
Table 133. Authors List of This Report
Table 134. Secondary Sources
Table 135. Primary Sources
List of Figures
Figure 1. Botanical Drug Product Picture
Figure 2. Global Botanical Drug Market Size Growth Rate by Type (US$ Million), 2019 VS 2023 VS 2030
Figure 3. Global Botanical Drug Market Size Share 2019 VS 2023 VS 2030
Figure 4. Prescription Drug Picture
Figure 5. OTC Picture
Figure 6. Global Botanical Drug Market Size Growth Rate by Application (US$ Million), 2019 VS 2023 VS 2030
Figure 7. Global Botanical Drug Market Size Share 2019 VS 2023 VS 2030
Figure 8. Cardiovascular Picture
Figure 9. Tumor Picture
Figure 10. Respiratory System Picture
Figure 11. Others Picture
Figure 12. Global Botanical Drug Market Size (US$ Million) & (2019-2030)
Figure 13. Global Botanical Drug Market Size, (US$ Million), 2019 VS 2023 VS 2030
Figure 14. Global Botanical Drug Market Share by Region: 2019 VS 2023 VS 2030
Figure 15. Global Botanical Drug Players Revenue Share Top 10 and Top 5 in 2023
Figure 16. Players Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
Figure 17. Global Botanical Drug Revenue by Type (2019 VS 2023 VS 2030) & (US$ Million)
Figure 18. Global Botanical Drug Revenue Market Share 2019 VS 2023 VS 2030
Figure 19. Global Botanical Drug Revenue Market Share by Type (2019-2030)
Figure 20. Global Botanical Drug Revenue by Application (2019 VS 2023 VS 2030) & (US$ Million)
Figure 21. Global Botanical Drug Revenue Market Share by Application (2019 VS 2023 VS 2030)
Figure 22. Global Botanical Drug Revenue Market Share by Application (2019-2030)
Figure 23. North America Botanical Drug Revenue YoY Growth (2019-2030) & (US$ Million)
Figure 24. North America Botanical Drug Revenue by Type (2025-2030) & (US$ Million)
Figure 25. North America Botanical Drug Revenue Share by Type (2019-2030)
Figure 26. North America Botanical Drug Revenue by Application (2025-2030) & (US$ Million)
Figure 27. North America Botanical Drug Revenue Share by Application (2019-2030)
Figure 28. North America Botanical Drug Revenue Share by Country (2019-2030)
Figure 29. United States Botanical Drug Revenue YoY Growth (US$ Million) & (2019-2030)
Figure 30. Canada Botanical Drug Revenue YoY Growth (US$ Million) & (2019-2030)
Figure 31. Europe Botanical Drug Revenue YoY Growth (2019-2030) & (US$ Million)
Figure 32. Europe Botanical Drug Revenue by Type (2025-2030) & (US$ Million)
Figure 33. Europe Botanical Drug Revenue Share by Type (2019-2030)
Figure 34. Europe Botanical Drug Revenue by Application (2025-2030) & (US$ Million)
Figure 35. Europe Botanical Drug Revenue Share by Application (2019-2030)
Figure 36. Europe Botanical Drug Revenue Share by Country (2019-2030)
Figure 37. Germany Botanical Drug Revenue YoY Growth (US$ Million) & (2019-2030)
Figure 38. France Botanical Drug Revenue YoY Growth (US$ Million) & (2019-2030)
Figure 39. U.K. Botanical Drug Revenue YoY Growth (US$ Million) & (2019-2030)
Figure 40. Italy Botanical Drug Revenue YoY Growth (US$ Million) & (2019-2030)
Figure 41. Russia Botanical Drug Revenue YoY Growth (US$ Million) & (2019-2030)
Figure 42. Nordic Countries Botanical Drug Revenue YoY Growth (US$ Million) & (2019-2030)
Figure 43. China Botanical Drug Revenue YoY Growth (2019-2030) & (US$ Million)
Figure 44. China Botanical Drug Revenue by Type (2025-2030) & (US$ Million)
Figure 45. China Botanical Drug Revenue Share by Type (2019-2030)
Figure 46. China Botanical Drug Revenue by Application (2025-2030) & (US$ Million)
Figure 47. China Botanical Drug Revenue Share by Application (2019-2030)
Figure 48. Asia Botanical Drug Revenue YoY Growth (2019-2030) & (US$ Million)
Figure 49. Asia Botanical Drug Revenue by Type (2025-2030) & (US$ Million)
Figure 50. Asia Botanical Drug Revenue Share by Type (2019-2030)
Figure 51. Asia Botanical Drug Revenue by Application (2025-2030) & (US$ Million)
Figure 52. Asia Botanical Drug Revenue Share by Application (2019-2030)
Figure 53. Asia Botanical Drug Revenue Share by Country (2019-2030)
Figure 54. Japan Botanical Drug Revenue YoY Growth (US$ Million) & (2019-2030)
Figure 55. South Korea Botanical Drug Revenue YoY Growth (US$ Million) & (2019-2030)
Figure 56. India Botanical Drug Revenue YoY Growth (US$ Million) & (2019-2030)
Figure 57. Australia Botanical Drug Revenue YoY Growth (US$ Million) & (2019-2030)
Figure 58. China Taiwan Botanical Drug Revenue YoY Growth (US$ Million) & (2019-2030)
Figure 59. Southeast Asia Botanical Drug Revenue YoY Growth (US$ Million) & (2019-2030)
Figure 60. MEALA Botanical Drug Revenue YoY Growth (2019-2030) & (US$ Million)
Figure 61. MEALA Botanical Drug Revenue by Type (2025-2030) & (US$ Million)
Figure 62. MEALA Botanical Drug Revenue Share by Type (2019-2030)
Figure 63. MEALA Botanical Drug Revenue by Application (2025-2030) & (US$ Million)
Figure 64. MEALA Botanical Drug Revenue Share by Application (2019-2030)
Figure 65. MEALA Botanical Drug Revenue Share by Country (2019-2030)
Figure 66. Mexico Botanical Drug Revenue YoY Growth (US$ Million) & (2019-2030)
Figure 67. South Korea Botanical Drug Revenue YoY Growth (US$ Million) & (2019-2030)
Figure 68. Brazil Botanical Drug Revenue YoY Growth (US$ Million) & (2019-2030)
Figure 69. Israel Botanical Drug Revenue YoY Growth (US$ Million) & (2019-2030)
Figure 70. Argentina Botanical Drug Revenue YoY Growth (US$ Million) & (2019-2030)
Figure 71. Colombia Botanical Drug Revenue YoY Growth (US$ Million) & (2019-2030)
Figure 72. Turkey Botanical Drug Revenue YoY Growth (US$ Million) & (2019-2030)
Figure 73. Saudi Arabia Botanical Drug Revenue YoY Growth (US$ Million) & (2019-2030)
Figure 74. UAE Botanical Drug Revenue YoY Growth (US$ Million) & (2019-2030)
Figure 75. Years Considered
Figure 76. Research Process
Figure 77. Key Executives Interviewed
